We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Ofsted has today published the findings from phase 2 of its independent review of teachers’ professional development in schools.
Advice to Rupert McNeil, former Government Chief People Officer, Cabinet Office, on business appointments after leaving Crown service
FCDO travel advice for Switzerland. Includes safety and security, insurance, entry requirements and legal differences.
Check how the advice and information we give applies to you, what you can expect from us and what to do if you think you have incorrect information.
There is a risk of harmful drug interactions with the ritonavir component of the COVID-19 treatment Paxlovid▼ due to its inhibition of the enzyme CYP3A, which metabolises many commonly used drugs. Prescribers should obtain a detailed patient history of current...
Advice to Matthew Sinclair, former Chief Economic Adviser to the Prime Minister, on business appointments after leaving Crown service.
Sections (3.01 - 3.101) last updated: April 2024.
During Debt Awareness Week, we talk to Neil Sutton, a senior leader within the bankruptcy and Debt Relief Order teams at the Insolvency Service, about some of the options that can help people on their journey out of debt.
Employment Tribunal decision.
Neuraxpharm UK Ltd is recalling specific batches after retesting showed out of specification results. The tabled batches are being recalled as a precautionary measure after testing showed variability of the capsule contents beyond permitted levels.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).